Related Experiment Video
Updated: Feb 14, 2026

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma
Yuko Kinowaki1, Morito Kurata1, Sachiko Ishibashi1
1Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Abstract:
Regulation of oxidative stress and redox systems has important roles in carcinogenesis and cancer progression, and for this reason has attracted much attention as a new area of cancer therapeutic targets. Glutathione peroxidase 4 (GPX4), an antioxidant enzyme, has biological important functions such as signaling cell death by suppressing peroxidation of membrane phospholipids. However, few studies exist on the expression and clinical relevance of GPX4 in malignant lymphomas such as diffuse large B-cell lymphoma. In this study, we assessed the expression of GPX4 immunohistochemically. GPX4 was expressed in 35.5% (33/93) cases of diffuse large B-cell lymphoma. The GPX4-positive group had poor overall survival (P = 0.0032) and progression-free survival (P = 0.0004) compared with those of the GPX4-negative group. In a combined analysis of GPX4 and 8-hydroxydeoxyguanosine (8-OHdG), an oxidative stress marker, there was a negative correlation between GPX4 and 8-hydroxydeoxyguanosine (P = 0.0009). The GPX4-positive and 8-hydroxydeoxyguanosine-negative groups had a significantly worse prognosis than the other groups in both overall survival (P = 0.0170) and progression-free survival (P = 0.0005). These results suggest that the overexpression of GPX4 is an independent prognostic predictor in diffuse large B-cell lymphoma. Furthermore, in vitro analysis demonstrated that GPX4-overexpressing cells were resistant to reactive oxygen species-induced cell death (P = 0.0360). Conversely, GPX4-knockdown cells were sensitive to reactive oxygen species-induced cell death (P = 0.0111). From these data, we conclude that GPX4 regulates reactive oxygen species-induced cell death. Our results suggest a novel therapeutic strategy using the mechanism of ferroptosis, as well as a novel prognostic predictor of diffuse large B-cell lymphoma.
Insights
Glutathione peroxidase 4 (GPX4) overexpression predicts poor survival in diffuse large B-cell lymphoma. GPX4 regulates cell death, suggesting ferroptosis-based therapies and GPX4 as a prognostic marker for this cancer.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Oxidative stress and redox system regulation are critical in cancer development and progression.
- Glutathione peroxidase 4 (GPX4), an antioxidant enzyme, plays a role in cell death by inhibiting membrane phospholipid peroxidation.
- Limited research exists on GPX4 expression and clinical significance in malignant lymphomas, including diffuse large B-cell lymphoma (DLBCL).
Purpose of the Study:
- To investigate the expression of GPX4 in diffuse large B-cell lymphoma (DLBCL).
- To evaluate the clinical relevance of GPX4 expression as a prognostic predictor in DLBCL.
- To explore the role of GPX4 in regulating cell death, particularly in response to reactive oxygen species (ROS).
Main Methods:
- Immunohistochemical analysis was used to assess GPX4 expression in 93 DLBCL cases.
- Correlation between GPX4 expression, 8-hydroxydeoxyguanosine (8-OHdG) levels (an oxidative stress marker), and patient survival (overall and progression-free) was analyzed.
- In vitro studies were conducted to examine the effect of GPX4 overexpression and knockdown on cell death induced by reactive oxygen species.
Main Results:
- GPX4 was expressed in 35.5% of DLBCL cases.
- GPX4-positive DLBCL patients exhibited significantly poorer overall survival and progression-free survival compared to GPX4-negative patients.
- A negative correlation was observed between GPX4 expression and 8-OHdG levels. GPX4-positive/8-OHdG-negative cases showed the worst prognosis.
- GPX4 overexpression conferred resistance to ROS-induced cell death, while GPX4 knockdown sensitized cells to ROS-induced death.
Conclusions:
- GPX4 overexpression is an independent prognostic predictor for poor outcomes in diffuse large B-cell lymphoma.
- GPX4 plays a crucial role in regulating reactive oxygen species-induced cell death, potentially through ferroptosis.
- These findings suggest GPX4 as a potential therapeutic target and prognostic biomarker for DLBCL.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Diffusion
Diffusion
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...

